Albemarle Impairment and restructuring increased by 1014.4% to $25.87M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3205.2%, from -$833.00K to $25.87M. This is a positive signal — lower values indicate better performance for this metric.
High levels indicate significant operational disruption or strategic realignment, often impacting short-term profitability.
The aggregate expense recognized for asset write-downs and costs associated with restructuring operations, such as facil...
Frequently used by capital-intensive firms to isolate non-recurring costs from core operating performance.
msft_impairment_and_restructuring| Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $297.47M | $860.86M | -$833.00K | $4.28M | $2.32M | $25.87M |
| QoQ Change | — | +189.4% | -100.1% | +614.3% | -45.8% | >999% |
| YoY Change | — | — | — | -98.6% | -99.7% | >999% |